{"entity":{"id":"nct06478108","kind":"trial","name":"Interventional Software for Multi-immunotherapy of Solid Tumors","aka":[],"tldr":"A phase 2/3 trial in lung cancer, run by Second Affiliated Hospital of Guangzhou Medical University, now recruiting.","summary":"Interventional Software for Multi-immunotherapy of Solid Tumors is a phase 2/3, interventional study registered as NCT06478108 by Second Affiliated Hospital of Guangzhou Medical University, with a registry enrolment figure of 60 participants, started 2024-04-01 and due to reach its primary completion in 2028-12-30. Interventions recorded: IRSW-MIM. Conditions listed: Lung Cancer; Liver Cancer; Solid Tumor, Adult. Primary outcome: Safety of the reccommended treatment generated by the medical device; Progression-free survival; Disease control rate. Sites: China. No results are recorded here; the registry entry is the source.","status":"recruiting","asOf":"2026-09-25","links":[{"label":"ClinicalTrials.gov NCT06478108","url":"https://clinicaltrials.gov/study/NCT06478108"}],"tags":["ctgov-ingest","lung-deep-dive"],"related":[],"cancers":["lung-cancer"],"sections":[],"technologies":[],"targets":[],"drugs":[],"companies":[],"institutions":[],"pathways":[],"terms":[],"trials":[],"people":[],"bottlenecks":[],"keyPapers":[],"journals":[],"dependsOn":[],"notes":[],"nct":"NCT06478108","phase":"2/3","setting":"Interventional Software IRSW-MIM Guided Immunotherapy for Advanced Solid Tumors: a Phase II Clinical Trial.","sponsor":"Second Affiliated Hospital of Guangzhou Medical University","enrolled":60,"enrolledBasis":"registry","outcomes":[]},"route":"/trials/nct06478108/","neighbours":{"cancer":[{"id":"lung-cancer","kind":"cancer","name":"Lung cancer (all types)","route":"/cancers/lung-cancer/"}],"term":[{"id":"lung-trials-open-today","kind":"term","name":"Lung cancer trials open today (registry snapshot)","route":"/terms/lung-trials-open-today/"}]}}